Barriers to medications for opioid use disorder in the court system: provider availability, provider “trustworthiness,” and cost
Abstract Background Medications for opioid use disorder (MOUD) significantly decrease mortality but courts rarely refer participants with opioid use disorder to MOUD providers. Previous qualitative work suggests routine court referrals to MOUD providers are more likely if court team members perceive...
Main Authors: | Fatema Z. Ahmed, Barbara Andraka-Christou, M.H. Clark, Rachel Totaram, Danielle N. Atkins, Brandon del Pozo |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2022-07-01
|
Series: | Health & Justice |
Subjects: | |
Online Access: | https://doi.org/10.1186/s40352-022-00188-4 |
Similar Items
-
Multimodal Acute Pain Management in the Parturient with Opioid Use Disorder: A Review
by: Koltenyuk V, et al.
Published: (2024-02-01) -
Prior authorization restrictions on medications for opioid use disorder: trends in state laws from 2005 to 2019
by: Barbara Andraka-Christou, et al.
Published: (2023-12-01) -
Pharmacotherapy for opioid dependence in jails and prisons: research review update and future directions
by: Sharma A, et al.
Published: (2016-04-01) -
A national survey of state laws regarding medications for opioid use disorder in problem-solving courts
by: Barbara Andraka-Christou, et al.
Published: (2022-03-01) -
Perceptions of buprenorphine barriers and efficacy among nurse practitioners and physician assistants
by: Barbara Andraka-Christou, et al.
Published: (2022-08-01)